Banas Finance (509053)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 0.48 offers a significant discount to stated book value of ₹20.50 per share.
• Current price ₹9.80 versus book value ₹20.50 provides a potential margin of safety if assets are fairly valued.
• Market cap is only ₹88 Cr, making it a small, obscure asset play candidate.
• The 52-week range of ₹5.01 to ₹9.89 shows the stock has attracted buyers despite weak fundamentals.

Concerns

• ROE of -16.63% and ROCE of -22.62% indicate ongoing destruction of shareholder capital.
• Latest quarter net loss of ₹41 Cr against sales of ₹13 Cr is deeply alarming.
• Piotroski F-Score of 2/9 points to very poor financial health.
• Sales growth of -57.64% and profit growth of -15,476.92% show a collapsing operating trajectory.

AI Analysis

At ₹9.80, Banas Finance tempts me with a price-to-book of 0.48 and a book value of ₹20.50. Benjamin Graham taught me to buy a rupee of assets for less than fifty paise, but only if the assets are real and earning power exists. Here, the earning power is missing. ROE is -16.63%, ROCE is -22.62%, and latest quarter sales of ₹13 Cr produced a net loss of ₹41 Cr. Profit growth of -15,476% is not a typo; it is a destruction of shareholder value. The Piotroski F-Score of 2/9 reinforces that the financial condition is deteriorating. Sales have collapsed by 57.64%, and no dividend is being paid. I cannot rely on P/E because earnings are negative; this is not a quality business. It is a possible asset play, but only if book value is trustworthy. The company is an investment company, so its assets may be securities or stakes whose market values can change quickly. I would demand to see the asset schedule, mark-to-market policy, and any debt obligations. Promoter holding is N/A, and there is insufficient data for a FairStock score—uncomfortable for a shareholder. The share has moved from ₹5.01 to ₹9.89, and at ₹9.80 it sits near the top of the 52-week range; that shows speculative enthusiasm, not fundamental proof. I would not pay ₹9.80 for this. I might be interested only at a larger margin of safety, and only after understanding why book value is not being protected by earnings. This is a cigar-butt candidate, not a compounding machine.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer